Drake Hogestyn’s passing of pancreatic cancer last September, left us all shocked and heartbroken. John Black has been such ...

TRIFOUR is Cantargia's first randomized, controlled study of nadunolimabFirst preliminary efficacy results expected mid-2025 LUND, SWEDEN / ACCESS Newswire / March 10, 2025 / Cantargia (Cantargia AB); ...

REHOVOT, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: ...

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and ...

Harrogate teenagers are embarking on epic trekking challenges in the UK and Nepal in memory of a beloved former primary ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients, but it’s ...

Friends, family, and the Cathedral Prep community gathered at the Hagerty Family Events Center to honor the legendary Pat ...

The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

A Tulsa man is transforming a challenging diagnosis into a meaningful legacy. He is providing hope and comfort, one cap at a ...

Join the Pancreatic Cancer Action Network and CBS47/FOX30 Action News Jax First Alert Weather Chief Meteorologist Mike Buresh ...

The FDA cleared the investigational new drug application for MRANK-106, a dual WEE1/YES1 kinase inhibitor, targeting advanced ...